RxNorm · SBD · 1293461

1293461

SBD · Branded drug

atropine sulfate 0.06 MG / benzoic acid 9 MG / hyoscyamine sulfate 0.06 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG Delayed Release Oral Tablet [Uritact]

Concept
RxCUI1293461
Nameatropine sulfate 0.06 MG / benzoic acid 9 MG / hyoscyamine sulfate 0.06 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG Delayed Release Oral Tablet [Uritact]
Term typeSBD · Branded drug
LanguageENG
SuppressO
Cross-maps
UMLS CUIC3464969
Synonyms

No additional synonyms recorded.

# same page, as API
GET autoicdapi.com/api/v1/reference/rxnorm/1293461
GET autoicdapi.com/api/v1/translate?code=1293461&from=rxnorm&to=umls

Common questions

What is the RxNorm code for atropine sulfate 0.06 MG / benzoic acid 9 MG / hyoscyamine sulfate 0.06 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG Delayed Release Oral Tablet [Uritact]?

atropine sulfate 0.06 MG / benzoic acid 9 MG / hyoscyamine sulfate 0.06 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG Delayed Release Oral Tablet [Uritact] is coded as 1293461 in RxNorm.

What is RxNorm code 1293461?

1293461 is the RxNorm identifier for atropine sulfate 0.06 MG / benzoic acid 9 MG / hyoscyamine sulfate 0.06 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG Delayed Release Oral Tablet [Uritact]. It is included in the current monthly NLM RxNorm release.

What term type is RxCUI 1293461?

1293461 is a SBD (Branded drug) in RxNorm.

What is the UMLS mapping for 1293461?

1293461 maps to UMLS C3464969.

RxNorm, plainly answered

What is RxNorm?
RxNorm is the NLM's normalized naming system for clinical drugs and dose forms. It collapses brand variants, packaging differences, and source-vocabulary noise into a single, stable identifier (RxCUI) per concept, with explicit links to ingredients, brands, and clinical drug forms.
What are RxCUIs?
An RxCUI is the persistent ID for a single RxNorm concept. The same RxCUI keeps pointing at the same drug concept release after release, even when names or sources change. That stability is what makes RxNorm useful for medication reconciliation and analytics.
How does RxNorm relate to NDC codes?
NDC codes describe a specific package SKU at a specific manufacturer. RxNorm describes the clinically relevant drug. One RxCUI can map to dozens of NDCs (different manufacturers, different package sizes), and we list those NDC mappings on each concept page.
How does RxNorm cross-map to other standards?
RxNorm concepts carry direct links to UMLS CUIs and SNOMED CT product codes when available. Through the UMLS bridge they can also reach ICD-10 codes (for instance, for indication-based coding) and LOINC observations. Our API exposes all of this on the cross_references field.
Is the API free to use?
Browsing concepts is free. Programmatic access at /api/v1/reference/rxnorm/* requires an API key. RxNorm itself is in the public domain, so there is no upstream license fee, but our bandwidth and uptime are not.
How fresh is the RxNorm data?
RxNorm releases monthly. We rebuild within a few business days of each release, and the concept-id history is preserved so previous lookups continue to resolve.